Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Santa Rosa Orthopaedic’s Hand Center Now Offering Platelet Rich Plasma Therapy (PRP) for Patients with Chronic Pain Issues
  • USA - English


News provided by

JB Communications

Aug 21, 2016, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Kai-Uwe Mazur and Dr. Dominic Mintalucci
Dr. Kai-Uwe Mazur and Dr. Dominic Mintalucci

Santa Rosa, CA (PRWEB) August 21, 2016 -- When it comes to the treatment of both acute and chronic soft tissue injuries, platelet-rich plasma injection (PRP) is a therapeutic procedure that is non-surgical, acts to reduce pain and provide long-term relief. New studies have recently indicated that PRP may also offer increased healing potential in tissues surrounding an injury.

This procedure helps to enhance the body's natural healing response, and generally results in pain relief, ultimately helping the patient to return to normal activities.

Post this

“PRP is a relatively simple procedure,” explains SRO orthopaedic surgeon Dominic J. Mintalucci, M.D. “It involves collecting blood from the patient then separating the blood platelets using centrifuge, followed by injecting the nutrient rich platelets back into the patient's site of injury. This procedure helps to enhance the body's natural healing response, and generally results in pain relief, ultimately helping the patient to return to normal activities.”

A Brief History of PRP

PRP has been around since the 1970s and was first used in an open heart surgery as early as 1987. Doctors have used Platelet Rich Plasma therapy on an increasing basis since the mid-1990s focused primarily on repairing bone structures following spinal injury and aiding in soft tissue recovery following plastic surgery.

From early 2000 onward orthopaedic surgeons and reconstructive specialists have reported that PRP helps to enhance the body’s natural healing process in both bone and tissue, while offering pain relief to patients with chronic pain issues. “More and more scientific studies are now supporting the fact that non-invasive PRP treatments have the potential to support cartilage health and reduce pain,” Dr. Mintalucci says.

What are Platelets?

Platelets are cells that clot blood and contain over 300 active growth factors. They also contain hormones that help to facilitate growth and healing. The process of extraction followed by centrifugation of the blood allows platelet-rich plasma to be separated from the original sample which is then injected into the site of the injury. For those patients whose tissues are aging and therefore have a slower or reduced ability to repair and regenerate, the growth factors in PRP can help to improve the body’s healing ability.

How is PRP Different from Stem Cell Therapy

Stem cell therapy and PRP therapy are among the newest advanced regenerative treatments available today, and they are often confused with one another. While stem cells have the ability to differentiate and form brand new cells, platelets are a small fragment of blood cells, which help in clotting and enhance the healing process. The growth factors present in the platelets work to simulate those cells essential for a quicker recovery.

Most recently, famous athletes like Tiger Woods, Kobe Bryant and A-Rod have all been in the news for their use of PRP, presumably helping to keep them at the top of their game. Researchers support the many positive findings of athletes.One recent study conducted by the University of Alberta reported improvements in pain and mobility as well as improvements in the tissue in a group of patients suffering from rotator cuff tendinopathy. Results were evident in MRIs taken before and after which showed structural change and a decrease in the size of tears.

“We are finding that our patients who are treated with PRP injections also report improvements in pain and mobility,” says SRO Hand Center’s Dr. Kai-Uwe Mazur. “The evidence that these treatments may work to improve the healing in the surrounding tissue is encouraging for other patients who might like to take advantage of this procedure.”

An added benefit of PRP therapy is that the patient faces less risk of infection or allergic reactions due to the procedure, as the injected platelets are of their own blood. This combined with the fact that the procedure itself is quick and does not require general anesthesia or a prolonged recovery makes it a viable option for situations where standard treatments have proven to be ineffective.

About SRO

Dr. Mazur and Dr. Mintalucci both provide PRP injections to promote quicker healing and less pain as a compliment to the many other advanced surgeries and treatment options available to patients through the Hand Center. PRP treatments are also available through the Centers of Excellence from other SRO surgeons.

The SRO Hand Center affords each patient state-of-the-art medical care in a friendly and compassionate environment. The SRO team treatment model focuses on diagnostics and meticulous surgical details, in addition to carefully monitored post-surgical rehabilitation and recovery. For more information, visit the SRO website. For a consultation call 707-546-1922 (option #1) and request an appointment.

John Beilharz, JB Communications, http://jbadvertising.com/, +1 (707) 579-4977, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.